ATLANTA, Ga. (WIVB) – More than 593,000 asthma inhalers are being recalled by GlaxoSmithKline, a pharmaceutical company.
According to pharmaphorum.com, the inhalers administer fewer doses of medicine than they say they do.
The products that are affected are just in the United States. They were made in North Carolina.
The defect poses no danger to patients.